- Home
- CRVO vs KBSX Comparison
CRVO vs KBSX Comparison
Compare CRVO & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- KBSX
- Stock Information
- Founded
- CRVO 2001
- KBSX N/A
- Country
- CRVO United States
- KBSX Taiwan
- Employees
- CRVO N/A
- KBSX N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- KBSX Recreational Games/Products/Toys
- Sector
- CRVO Health Care
- KBSX Consumer Discretionary
- Exchange
- CRVO Nasdaq
- KBSX Nasdaq
- Market Cap
- CRVO 98.3M
- KBSX 104.0M
- IPO Year
- CRVO N/A
- KBSX N/A
- Fundamental
- Price
- CRVO $2.11
- KBSX N/A
- Analyst Decision
- CRVO Buy
- KBSX
- Analyst Count
- CRVO 8
- KBSX 0
- Target Price
- CRVO $38.75
- KBSX N/A
- AVG Volume (30 Days)
- CRVO 303.4K
- KBSX N/A
- Earning Date
- CRVO 11-12-2024
- KBSX N/A
- Dividend Yield
- CRVO N/A
- KBSX N/A
- EPS Growth
- CRVO N/A
- KBSX N/A
- EPS
- CRVO N/A
- KBSX N/A
- Revenue
- CRVO $10,066,550.00
- KBSX N/A
- Revenue This Year
- CRVO $34.17
- KBSX N/A
- Revenue Next Year
- CRVO N/A
- KBSX N/A
- P/E Ratio
- CRVO N/A
- KBSX N/A
- Revenue Growth
- CRVO 116.29
- KBSX N/A
- 52 Week Low
- CRVO $1.80
- KBSX N/A
- 52 Week High
- CRVO $26.38
- KBSX N/A
- Technical
- Relative Strength Index (RSI)
- CRVO 28.68
- KBSX N/A
- Support Level
- CRVO $2.03
- KBSX N/A
- Resistance Level
- CRVO $2.17
- KBSX N/A
- Average True Range (ATR)
- CRVO 0.16
- KBSX 0.00
- MACD
- CRVO 0.30
- KBSX 0.00
- Stochastic Oscillator
- CRVO 23.08
- KBSX 0.00
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.